Ep. 44: How do patents work? Intellectual Property in Health Technology
Sun Jan 11 2026
The provided text serves as a strategic guide for scientists transitioning from laboratory research to the commercialisation of medical innovations. It details the Biodesign model, which prioritises identifying unmet clinical needs before developing technical solutions. The sources outline the rigorous regulatory pathways enforced by the FDA for both medical devices and pharmaceuticals, while explaining the legal requirements for securing intellectual property. Furthermore, the text highlights the importance of institutional support and legislation like the Bayh-Dole Act in navigating the complex journey from an initial concept to a marketable product.
More
The provided text serves as a strategic guide for scientists transitioning from laboratory research to the commercialisation of medical innovations. It details the Biodesign model, which prioritises identifying unmet clinical needs before developing technical solutions. The sources outline the rigorous regulatory pathways enforced by the FDA for both medical devices and pharmaceuticals, while explaining the legal requirements for securing intellectual property. Furthermore, the text highlights the importance of institutional support and legislation like the Bayh-Dole Act in navigating the complex journey from an initial concept to a marketable product.